Shangting Han

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Combination Therapy

Top Venues

Oxidative medicine and cellular longevity

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shangting Han, Jiayu Guo, Chenyang Kong, Jun Li, Fangyou Lin, Jiefu Zhu, Tianyu Wang, Qi Chen, Yiting Liu, Haochong Hu, Tao Qiu, Fan Cheng, Jiangqiao Zhou
ANKRD1 aggravates renal ischaemia‒reperfusion injury via promoting TRIM25-mediated ubiquitination of ACSL3. Clinical and translational medicine 14 (9) (2024)
Linxiang Zhou, Shangting Han, Jiayu Guo, Tao Qiu, Jiangqiao Zhou, Lei Shen
Ferroptosis-A New Dawn in the Treatment of Organ Ischemia-Reperfusion Injury. Cells 11 (22) (2022)
Shangting Han, Fang-You Lin, Yucheng Qi, Cong Liu, Linxiang Zhou, Yuqi Xia, Kang Chen, Ji Xing, Zilin Liu, Weimin Yu, Yunlong Zhang, Xiangjun Zhou, Ting Rao, Fan Cheng
HO-1 Contributes to Luteolin-Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation. Oxidative medicine and cellular longevity 2022 (2022)